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Abstract
Background:  A major goal in the post-genomic era is to identify and characterise disease
susceptibility genes and to apply this knowledge to disease prevention and treatment. Rodents and
humans have remarkably similar genomes and share closely related biochemical, physiological and
pathological pathways. In this work we utilised the latest information on the mouse transcriptome
as revealed by the RIKEN FANTOM2 project to identify novel human disease-related candidate
genes. We define a new term "patholog" to mean a homolog of a human disease-related gene
encoding a product (transcript, anti-sense or protein) potentially relevant to disease. Rather than
just focus on Mendelian inheritance, we applied the analysis to all potential pathologs regardless of
their inheritance pattern.
Results: Bioinformatic analysis and human curation of 60,770 RIKEN full-length mouse cDNA
clones produced 2,578 sequences that showed similarity (70–85% identity) to known human-
disease genes. Using a newly developed biological information extraction and annotation tool
(FACTS) in parallel with human expert analysis of 17,051 MEDLINE scientific abstracts we
identified 182 novel potential pathologs. Of these, 36 were identified by computational tools only,
49 by human expert analysis only and 97 by both methods. These pathologs were related to
neoplastic (53%), hereditary (24%), immunological (5%), cardio-vascular (4%), or other (14%),
disorders.
Conclusions: Large scale genome projects continue to produce a vast amount of data with
potential application to the study of human disease. For this potential to be realised we need
intelligent strategies for data categorisation and the ability to link sequence data with relevant
literature. This paper demonstrates the power of combining human expert annotation with FACTS,
a newly developed bioinformatics tool, to identify novel pathologs from within large-scale mouse
transcript datasets.
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Background
The majority of common diseases such as cancer, allergy,
diabetes or heart disease are characterised by complex
genetic traits where genetic and environmental compo-
nents contribute to disease susceptibility [1]. Unfortu-
nately, our knowledge of genes contributing to the risk of
common diseases remains limited. Consequently, a major
goal of the post-genomic era is to better identify and char-
acterise disease susceptibility genes and to use this knowl-
edge for improved disease detection, treatment and
prevention.
More than 500 genes are conserved across the invertebrate
and vertebrate genomes [2]. Because of gene conservation,
various organisms including yeast [3], fruitfly [4],
zebrafish [5], rat [6], and mouse [7] have been used as
genetic models for the study of human disease. Whilst the
basic housekeeping genes such as those involved in
metabolism, intracellular signalling, transcription/trans-
lation, DNA replication and repair are highly conserved in
eukaryotes making them useful for the study of basic cel-
lular processes and related diseases, these organisms do
not share with humans many genes such as those involved
in homeostasis, immunity, and cellular interactions [2].
Rodents and humans have remarkably similar genomes
and share closely related biochemical, physiological and
pathological pathways making the mouse the most
important model organism for the study of human dis-
ease genetics and development of new treatments. This is
reflected in the fact that approximately 80% of all mouse
cDNA clones have matches in the human genome [2].
Genetic manipulations that can be performed in the
mouse include point mutations, gene disruptions, inser-
tions, deletions, or chromosomal rearrangements [8].
Random genome-wide mutagenesis can also be used for
identification of gene function [9]. Specific genetic
manipulations and alterations in the mouse often pro-
duce clinical features that are remarkably similar to
human disease [10]. For example, targeted mutation of
the transferrin receptor-2 gene was shown to induce
haemochromatosis in mice [11]. The recent explosion of
genomic data has, however, overwhelmed researchers
with tens of thousands of novel genes making it difficult
to know where to start in order to identify those most rel-
evant to human disease. This has led to the use of compar-
ative genomics as a strategy to identify promising
candidates warranting further study from amongst all
these novel genes.
Rubin et al. [12] compiled a list of 289 human disease
genes and compared them to the fruitfly genome, finding
177 fruitfly orthologues to human disease genes. A more
recent study [4] focused on identification of a subset of
human disease genes that represent good candidates for
study in the fruitfly model. Starting from the 929 entries
of known human disease genes listed in the OMIM data-
base [13], they identified 548 fruitfly genes with sequence
homology to human disease genes. Of these, 56 genes
belonged to well-known signalling pathways (such as
BMP, Hedgehog or Notch). These strategies starting from
known human disease-related genes are directed at the
identification of orthologs in non-human species of
known human disease genes.
The FANTOM2 project [14] focused on the functional
annotation of 60770 cDNA RIKEN clones by large-scale,
computerised annotation followed by manual curation.
Being the most complete picture of the mouse transcrip-
tome to date, the FANTOM2 dataset provides an ideal
opportunity for the identification of novel pathologs
thereby leading to the identification of novel human dis-
ease-related genes or disease-related gene products (tran-
script, anti-sense or protein), including candidates not
listed in the OMIM Morbidmap database.
Recently, FANTOM2 cDNA clones were searched with
TBLASTN (e-value: E-50) against a set of human disease-
related genes and mouse orthologs were identified for 807
human disease-related genes [15]. Of these, 67 were novel
mouse orthologs for known human disease-related genes
[15]. However, this BLAST strategy starting from known
human disease-related genes and then searching for
orthologs in the mouse is only able to identify mouse
genes corresponding to already known human disease-
related genes. Consequently, for the present study we
developed an alternative strategy for gene discovery from
the FANTOM2 cDNA dataset aimed at identifying poten-
tial novel human disease-related genes. By comparison to
previous reports [15,12,4], we started from novel mouse
transcripts with similarity but not identity to human dis-
ease-related genes and then mapped these sequences back
to the human genome to identify novel potential human
disease-related genes.
The FANTOM2 dataset contains 2578 cDNA clones anno-
tated as "similar to" known genes or proteins, comprising
1114 members of the representative transcript protein set
6.3 (RTPS6.3) FANTOM2 clusters [14]. The sequences of
each of these "similar to" clones have 70–85% identity
over more than 70% length to known reference protein or
gene sequences. By searching the publication abstracts
databases PubMed/MEDLINE [16], we identified 182
mouse mRNA transcripts that we called "potential
pathologs" as they had sequence similarity to human dis-
ease-related genes or proteins. We defined "patholog" as a
non-human gene with homology to a human gene that
encodes a product (transcript, anti-sense or proteins)
involved in human disease. A disease-related gene has a
role in a patho-physiological pathway, or is relevant to theBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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diagnosis or treatment of a human disease. The most com-
mon disease classifications to which these potential
pathologs corresponded were neoplastic, hereditary,
immune, cardiovascular or neurological diseases. Each
patholog represents a potential target for creating novel
mouse models of human disease.
One of the bottlenecks in the use of genomic data to
search for potential disease genes, is the time required to
search the literature and assess the significance of the
search results. Semi-automated knowledge extraction
tools offer the potential to dramatically accelerate this
process, albeit at the risk of some loss of information as a
result of misqueries and ambiguous data. An important
aspect of this project was a comparison of the perform-
ance of FACTS, a newly developed semi-automated
knowledge extraction tool, against expert human annota-
tors to determine whether in the future it will be feasible
to automate the process of disease gene identification.
Results
Identification of novel pathologs
We identified 182 candidate pathologs from amongst
2578 FANTOM2 mouse "similar to" cDNA transcripts
(Figure 1). Each of the transcripts representing these tar-
gets shows 70–85% identity over more than 70% of its
length to a known human disease related gene or protein
found by sequence similarity comparisons (see Methods).
Of these, 146 were identified by manual and 133 by a
semi-automated approach with 97 (53.3%) of targets
being detected by both methods. The manual approach
uniquely detected 49 (26.9%) human disease-related
gene targets and semi-automated approach uniquely
detected 36 (19.8%) targets.
Classification of pathologs by disease
The 182 "pathologs" were classified by the disease they
relate to. The majority of the clones were related to neo-
plastic disorders (53%), followed by hereditary (24%),
immunological (5%), cardio-vascular (4%), and other
(14%), disorders (Table 1).
Cancer-related pathologs
The cancer-related category comprised the largest number
of potential pathologs, with 96 unique targets (Table 2).
Cancers represented in this list cover a variety of systems
including the central nervous system, gastro-intestinal
tract, breast, and prostate, among others. These potential
pathologs related to cancer pathophysiology 61 (63.5%),
diagnosis 19 (19.8%) and treatment 16 (16.7%).
Each of the 96 cancer-related potential pathologs was
associated with one of the molecular circuits that main-
tain normal cell proliferation and homeostasis. Defects in
these circuits often induce dysregulation of cell growth
and apoptosis, or contribute to tissue invasion, metasta-
sis, or angiogenesis. Defects in these pathways are thus
central to cancer development [17]. Amongst the
pathologs we identified genes encoding proteins involved
in the SOS-Ras-Raf-MAPK cascade that has a key role in
normal cell growth, and proteins linked with gene expres-
sion and cell proliferation, including Wnt-β Catenin,
CdC42-Rac-Rho, and the pRb-E2F transcription factors
[17]. A number of matrix metalloproteinases and cell
adhesion molecules involved in cell invasion and metas-
tasis were also identified.
Hereditary-disease pathologs
Potential pathologs related to hereditary diseases were the
second largest group in this study (Table 3). We found 43
transcripts related to hereditary diseases, of which 39
(90.7%) were described to be defective or deleted in
hereditary disorders and 4 (9.3%) were related to diagno-
sis. Defective pathways contributing to the pathogenesis
of these diseases included metabolic pathways (e.g.
Flow chart of method used for the identification of  "pathologs" Figure 1
Flow chart of method used for the identification of 
"pathologs". Obtained from the FANTOM2 dataset, "similar 
to" clones were analysed using a manual (left) and a semi-
automated approach (right) to identify "patholog" genes. 
HDR clones: clones with Human Disease Relationship.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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Table 1: Novel potential "pathologs" classified by type of human disorder and relationship to the disease process.
Disorder Pathophysiology Diagnosis Treatment Total
Cancer 61 19 16 96
Hereditary 39 4 0 43
Immunological 5 5 0 10
Cardio-vascular 8 0 0 8
Reproductive 6 0 0 6
Other 17 0 2 19
Total 136 28 18 182
Table 2: Cancer related pathologs. Representative disease is shown for each clone. * RTPS6.3 (representative transcript protein set 6.3) 
cluster representative transcriptional unit (TU) of the FANTOM2 clone set. OMIM status: 1 = gene present in OMIM with a reported 
disease; 2 = gene present in OMIM with different disease association or without disease; 3 = gene not present in OMIM.
Disease FANTOM ID DDBJ accession Gene name Disease relationship OMIM status
CANCER
Diagnosis
1110013A16* AK003650 Squamous cell carcinoma antigen 2 Squamous cell carcinoma 1
1300012C15* AK004970 Cargo selection protein tip47 Gynecologic malignancies 2
1600002M22* AK005400 Pregnancy-specific beta 1-glycoprotein Trophoblastic disease, tumour 
marker
1
1810011L16* AK007436 Adamts-9 precursor Hereditary renal tumors 3
2310046E09 AK009843 Pancreatic secretory granule 
membrane major glycoprotein gp2 
precursor
Chronic lymphocytic leukemia 2
2600013I19* AK011199 Diphthamide biosynthesis protein-2 Prognosis of neoplastic diseases 2
4631401E18* AK019470 Udp-n-acetyl-alpha-d-
galactosamine:polypeptide n-
acetylgalactosaminyl Transferase 7
Colorectal carcinoma 2
4930435F02 AK019597 3-oxo-5-alpha-steroid 4-
dehydrogenase 1
Breast cancer 3
4932411D20* AK029960 Ctcl tumor antigen se2-2 T-cell based immunotherapy 3
5330423N11* AK077331 Melastatin 2 Cutaneous malignant melanoma 3
9130023H10* AK033603 Mlze Melanoma 3
9130413M24* AK078964 Ctcl tumor antigen se57-1 T-cell based immunotherapy 3
9330156N18* AK034104 Desmoglein 1 precursor Paraneoplastic pemphigus 2
A030012E10* AK037235 Serine protease desc1 precursor Squamous cell carcinoma 3
A230060D07* AK038754 Reverse transcriptase-like protein Chronic myelogenous leukemia 3
A430037M23 AK039975 Dipeptidyl-peptidase iii Endometrial neoplasms 2
A630051G17 AK080312 Meningioma-expressed antigen 6/11 Meningioma and glioma 1
E130307D12* AK087504 Scaffold attachment Factor b Breast cancer 1
G430124K07* AK090101 Restricted expression proliferation 
associated protein 100
Lung carcinoma 3
Pathophysiology
0610006O14 AK002260 Vacuolar proton-atpase subunit atp6h Melanoma 2
0610008P16* AK002360 Hp33 protein Hepatocellular carcinoma 3
1110068E08* AK004405 Ku70-binding protein Gliomas 3
1200003O15* AK004587 Proto-oncogene tyrosine-protein 
kinase fes/fps
Leukaemia 1
1500012D09 AK005230 Ras-related protein rab-2 Nasopharyngeal carcinoma 1
1700001P03* AK005620 Homeobox transcription factor Colon cancer 1
1700006L01 Smac protein, mitochondrial 
precursor
Multiple myeloma 2
1700012B18* AK005892 Pregnancy-induced growth inhibitor Breast cancer 3
1700045I19* AK006700 Hsd-4 protein Prostate cancer 2
1810017F10* AK007525 Beta-casein-like protein Tumour-associated antigen 3
2010003F10* AK008064 Transmembrane 4 superfamily, 
member 5
Pancreatic cancer 1
2210006M16* AK008663 Gasdermin Human gastric cancer cells 3BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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2210007N23 AK019050 Ca11 protein homolog Gastric carcinogenesis 1
2210412D05 AK008907 Rho guanine nucleotide exchange 
factor 5
Acute myeloid leukaemia 1
2210414K06 AK008928 Nesh Cell metastasis and malignant 
transformation
2
2310016C08* AK009377 Hypoxia-inducible protein 2 Cervix cancer 3
2510002J07* AK010891 1-acyl-sn-glycerol-3-phosphate 
acyltransferase beta
Cancers and inflammation-
associated diseases.
2
2610002I10 AK011289 C-myc target jpo1 Tumourigenesis 3
2610005L07 AK011323 Cadherin Cancer development 1
2700048G21* AK012392 Antigen ny-co-8 Colon cancer antigen 3
2810411G23 AK013085 Tumor protein d54 Breast cancer 1
2810425C21* AK013153 Death domain of death-associated 
protein kinase 1
Non-small cell lung cancer 2
2810449N18* AK013316 Sirtuin 6 Thyroid carcinoma 2
2900009D12 AK013503 Succinate dehydrogenase Hereditary paraganglioma 1
4432412E01* AK014491 X-ray repair cross-complementing 
protein 3
Bladder-cancer 2
4631410F01 AK028459 Adamts-12 precursor Gastric carcinomas 3
4732440A06* AK028704 Calcium-activated chloride channel-2 Breast cancer, metastasis 2
4930500E24* AK019661 Gas-2 related protein on chromosome 
22
Central nervous system tumours 3
4932436B18* AK030081 Pms1 protein homolog 1 Prostate cancer 1
4933405E14* AK016662 Serologically defined colon cancer 
antigen 1
Tumour suppressor 3
4933409E02* AK016751 Retinoblastoma-associated protein 
rap140
Colon cancer cell line 3
5430417G24* AK030670 Headpin serine proteinase inhibitor Squamous cell carcinoma 1
5630400A09* AK030708 P63 protein Basal cell and squamous cell 
carcinomas
1
5730484M20* AK077629 Cell cycle checkpoint protein chfr Lung cancer 1
6430531D06* AK032385 Elks Capillary thyroid carcinoma 1
6430587E11 AK032541 Copine vii Breast cancer 1
6820401K01* AK033012 Npat Cancer development 2
9330137N20 AK079068 Hepatic leukemia factor Lymphoblastic leukaemia 1
9330200A01* AK034492 Ubiquitin specific protease Squamous non-small cell lung 
carcinoma
2
A130080E24* AK038118 C-myb protein Colon tumour 3
A430025E01* AK039888 P68 RNA helicase Colorectal tumours 2
A430075F05 AK040185 Lipoma preferred partner Acute myeloid leukaemia 1
A730042E07 AK042943 Serine/threonine protein phosphatase 
2a, 72/130 kda regulatory subunit B
Melanoma 2
A830098D13* AK044188 Megacaryocytic acute leukemia 
protein, isoform i
Acute megakaryoblastic leukemias 1
A930033B01 AK020920 Graf Hematopoeitic disorders 1
B130017M24 AK044984 Hepatocellular carcinoma 
autoantigen
Hepatocellular carcinoma 3
B230314N17 AK045848 Deleted in lung and esophageal 
cancer 1
Carcinogenesis 1
B930026D14* AK047144 Myc box dependent interacting 
protein 1
Prostate carcinoma 3
B930095M03* AK081171 Frat2 Gastric cancer 1
C130050F24* AK048341 Ranbp7/importin 7 Colorectal carcinoma 2
C130062I06* AK048462 Fibrillarin Hepatocellular carcinoma 1
C230012L01 AK048706 Androgen-induced prostate 
proliferative shutoff associated 
protein
Prostate cancer 1
C630001O15 AK049821 Malt1 MALT lymphoma 1
D330038I09 AK052361 10-formyltetrahydrofolate 
dehydrogenase
Tumour cells 2
E030001H09* AK086788 Phd finger protein 3 Glioblastoma multiforme 1
E030027H19* AK087108 Cub domain containing Protein 1 Human colorectal cancer 3
Table 2: Cancer related pathologs. Representative disease is shown for each clone. * RTPS6.3 (representative transcript protein set 6.3) 
cluster representative transcriptional unit (TU) of the FANTOM2 clone set. OMIM status: 1 = gene present in OMIM with a reported 
disease; 2 = gene present in OMIM with different disease association or without disease; 3 = gene not present in OMIM. (Continued)BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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peroxisomal biosynthesis and oxidation, mitochondrial
respiratory chain, and phospholipid biosynthesis),
cytoskeleton synthesis and organization and ion trans-
port. Interestingly, 11 gene products from this group were
previously described in the literature but their function
was unknown or putative.
Other pathologs
All other potential pathologs (immunological, neurologi-
cal, reproductive, cardiovascular, and others) have been
summarised in table 4. The immunological disorders-
related group comprised 10 transcripts. The majority of
them represent genes involved in autoimmune diseases
including systemic lupus erythematosus, rheumatoid
arthritis, Sjogren's syndrome, sarcoidosis and Crohn's dis-
ease. Eight of the transcripts in this group encode proteins
that have homology to known autoantigens. For neuro-
logical disorders, four potential pathologs related to
Alzheimer's or Huntington's disease. Some neurological
pathologs were also classified as hereditary disorder
pathologs because of their Mendelian inheritance pattern.
Six pathologs were related to reproductive disorders, eight
to cardiovascular disorders (mainly hypertension), and
15 to other diseases.
Identification of novel pathologs
These 182 transcripts were further analysed to find those
that by sequence comparison and conserved gene synteny
corresponded to potential new pathologs, classified as
"ortholog candidates" or "novel sequences" (Figure 2).
We found 137 pathologs that represented the most simi-
lar mouse sequences to known human genes. Of these, 72
(52.5%) were found in public databases (NCBI and SPTR)
as previously described mouse orthologs and their
function is known or inferred. The remaining 65 (47.5%)
represent the best mouse to human match by sequence
similarity but their function is not known, making them
excellent candidate mouse orthologs.
Of the 72 potential pathologs known to be mouse
orthologs, 33 (45.9%) were related to neoplastic disor-
ders, 23 (31.9%) to hereditary disorders and 16 (22.2%)
corresponded to immunological, cardio-vascular, repro-
ductive and other disorders. The majority of the 65
pathologs representing candidate mouse orthologs were
related to cancer (37 or 57%). The remaining transcripts
were related to the following disease categories: hereditary
disorders 13 transcripts (20%), immunological 4 (6%),
cardio-vascular 4 (6%), and other disease classification 7
E230037B21 AK054229 Vault poly(adp-ribose) polymerase Several tumour types 3
F630110I03 AK089273 Matrix metalloproteinase-25 
precursor
Colon carcinomas or brain 
tumours
3
F730035A01 AK089461 Swi/snf complex 170 kda subunit Malignant rhabdoid tumours 1
G630018E19* AK090207 Prostate cancer overexpressed gene 1 Prostate cancer 1
G630034H08* AK090280 Transcriptional repressor scratch Small cell lung cancer 3
Treatment
1100001P14 AK075618 Beta-tubulin class iva isotype Human colon adenocarcinoma 3
1200012D01* AK004723 Magic roundabout Angiogenesis 3
1810010L20 AK075773 Pituitary tumor-transforming gene 1 
protein-interacting protein
Pituitary adenomas 2
2310039D24* AK009689 Carboxylesterase Solid tumours 1
2600009M07 AK011174 Polyamine modulated factor-1 Antineoplastic activity 3
2810459H04 AK013366 Thrombospondin Angiogenesis 1
3010033I09* AK019405 Alex1 Tumours originating from 
epithelial tissue
1
5730405M22* AK077421 Phosphoprotein enriched in astrocytes 
15
Glioma 2
6030493E19 AK031701 Melanoma antigen p15 Melanoma 1
6230424I22* AK031785 NUCLEAR MATRIX PROTEIN p84 Tumor suppression 2
A730016J02 AK042696 Acetyltransferase tubedown-1 Vascular and haematopoietic 
development
3
B130023J22 AK045057 Greb1b Breast cancer 3
C920008O22 AK050594 Retinoblastoma-binding protein 1 Breast cancer 2
D030050C19 AK083587 Chronic myelogenous leukemia tumor 
antigen 66
Leukemias and tumour cell lines 1
D630010E08* AK052639 Carbonic anhydrase xii precursor Cancer tumour cells 1
D830007E07* AK052857 Inositol hexakisphosphate kinase 3 Ovarian cancer 2
Table 2: Cancer related pathologs. Representative disease is shown for each clone. * RTPS6.3 (representative transcript protein set 6.3) 
cluster representative transcriptional unit (TU) of the FANTOM2 clone set. OMIM status: 1 = gene present in OMIM with a reported 
disease; 2 = gene present in OMIM with different disease association or without disease; 3 = gene not present in OMIM. (Continued)BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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Table 3: Pathologs related to hereditary disorders. Representative disease is shown for each clone. * RTPS6.3 (representative transcript 
protein set 6.3) cluster representative transcriptional unit (TU) of the FANTOM2 clone set. OMIM status: 1 = gene present in OMIM 
with a reported disease; 2 = gene present in OMIM with different disease association or without disease; 3 = gene not present in OMIM.
Disease FANTOM ID DDBJ accession Gene name Disease relationship OMIM status
HEREDITARY
Diagnosis
1700026F24 AK006381 Neuronal protein 15.6 Neurogenetic disorders 3
2300002L19* AK009012 Chitotriosidase precursor Gaucher's disease 1
2700028P07 AK012300 14-3-3 protein tau Creutzfeldt-Jakob disease 3
4732420G08* AK028628 Methionine synthase reductase Methionine synthase reductase 
deficiency
1
Pathophysiology
1010001M04* AK003132 Nadh-ubiquinone oxidoreductase 20 
kda subunit, mitochondrial precursor
Mitochondrial complex I 
deficiency
1
1110019I12* AK003819 Selenoprotein n precursor Congenital muscular dystrophy 1
4930414M06 AK005847 Sterol carrier protein 2 Peroxisomal D-hydroxyacyl-CoA 
dehydrogenase deficiency
1
1810064C02 AK007951 Sedlin Spondyloepiphyseal dysplasia 
tarda
1
2310057L06 AK075908 Tubulin-specific chaperone d Retinitis pigmentosa 2
2410004F01* AK010385 Protoheme ix farnesyltransferase, 
mitochondrial precursor
Charcot-marie-tooth disease 1
2610205J09 AK011891 Periodic tryptophan Protein 1 Progressive myoclonus epilepsy 1
2900072D10* AK013765 Sco2 protein homolog, mitochondrial 
precursor
Cardioencephalomyopathy and a 
severe COX deficiency
1
3110031I02* AK014104 N-wasp protein Wiskott-Aldrich syndrome 1
4832440C16 AK029338 Apical-like protein Ocular albinism type 1 1
4930430B17 AK076748 Machado-joseph disease protein 1 Machado-joseph disease 1
5830404H04 AK017896 Protein c21orf2 Autoimmune polyglandular 
disease type I
1
6030476O14 AK031666 Myoferlin Muscular dystrophy and 
cardiomyopathy
1
6430516P20 AK032293 Ceroid-lipofuscinosis neuronal protein 
5
Late infantile neuronal ceroid 
lipofuscinosis
1
6430560A18 AK078275 Caltractin, isoform 2 Barth syndrome and 
chondrodysplasia punctata
2
8030487I16 AK033295 Gdp-fucose transporter 1 Leukocyte adhesion deficiency II 1
9330166I04* AK034236 Sialidase Sialidosis 1
6720416P20* AK032725 Zinc finger protein 25 MEN2a MEN2b 1
9630046L06 AK036225 Glycogen debranching enzyme Glycogen storage disease type III 1
9930121L06* AK037126 Artemis protein Athabascan SCID 3
A130054J05* AK037846 Nuclear localization signal protein 
absent in velo-cardio-facial patients
Velo-cardio-facial syndrome 1
A230074J06* AK038912 Nyctalopin X-linked congenital stationary 
night blindness
1
A230090N11* AK039054 Cyld protein Cylindromatosis 1
A630004L17 AK041354 Transmembrane protein vezatin Deafness 3
A730020L24 AK042745 Alkyl-dihydroxyacetonephosphate 
synthase
Zellweger syndrome 1
A830020B12 AK043682 Peroxisome assembly protein 10 Peroxisome-biogenesis disorders 1
A930007F16 AK044320 Inositol polyphosphate 5-
phosphatase ocrl-1
Lowe syndrome 1
A930014F04 AK044460 Mitochondrial intermediate 
peptidase, mitochondrial precursor
Friedreich's ataxia 1
B230307C21* AK045712 Epilepsy holoprosencephaly 
candidate-1 protein
Progressive myoclonus epilepsy 1
B230311E17 AK045797 Monocarboxylate transporter 5 Mitochondrial myopathies 2BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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(11%) which included neurological, haematological,
reproductive, endocrine, and respiratory disorders.
Classification of candidate orthologs and novel homologs
We also located 45 potential pathologs not representing
mouse orthologs of human genes, as there was a better
mouse transcript match for the human gene they share
sequence homology with. However, they may represent
novel mouse homologs as deducted from sequence anal-
ysis and conservation of synteny.
These 45 potential pathologs with novel sequences, corre-
sponded to cancer 26 (58%), hereditary disorders 7
(15%), cardiovascular disease 3 (7%) and other diseases 9
(20%). Nine of these targets had short sequences (less
than 1000 bp) and might correspond to pseudogenes
(based on gene synteny).
Comparison to Online Mendelian Inheritance in Man 
(OMIM) database entries
Genome-wide studies of pathologs in other organisms
[2,4,18] focused on systematic searches for paralogs or
orthologs of human disease genes in the respective
genomes. In those studies pathologs in different organ-
isms were detected using the OMIM database [19] that
contains entries on hereditary human disorders. We were
interested, however, in identifying potential pathologs
involved in both inherited and non-inherited diseases
and consequently elected to use a broader search strategy
focusing on sequence analysis combined with key-word
searching of literature abstracts based on annotated gene
names and MeSH terms. Scientific abstracts listed in
PubMed were searched to identify human disease-related
genes or proteins related to our dataset of "similar to"
FANTOM2 clones. In a comparison between the disease
genes listed in OMIM and those detected using PubMed,
we found that out of the 182 potential pathologs we
identified in this project, 128 (70.3%) were listed in
OMIM, but only 89 were listed as having a disease rela-
tionship (Table 5). For the remaining 39 pathologs either
B430307M20* AK046679 Ataxin 7 Spinocerebellar ataxia type 7 1
C130020P08 AK047906 Lowe oculocerebrorenal syndrome 
protein
Oculocerebrorenal syndrome of 
Lowe
1
C330001M22* AK049106 Ubash3a protein Autosomal recessive deafness 2
C330016K18* AK049248 Sodium bicarbonate cotransporter 
isoform 1
Proximal renal tubular acidosis 
associated with ocular 
abnormalities
1
C430015N23* AK049478 Y+l amino acid transporter 1 Lysinuric protein intolerance 1
D030003E11 AK050684 Beta-1,4-galactosyltransferase 7 Progeroid type Ehlers-Danlos 
syndrome
1
E130016P05 AK084312 T-box transcription factor tbx22 Cleft palate 1
D630003K02* AK085272 Cytochrome b5 reductase b5r.2 Methemoglobinemia 1
D630025L11* AK052697 Chorein Chorea-acanthocytosis 1
Table 3: Pathologs related to hereditary disorders. Representative disease is shown for each clone. * RTPS6.3 (representative transcript 
protein set 6.3) cluster representative transcriptional unit (TU) of the FANTOM2 clone set. OMIM status: 1 = gene present in OMIM 
with a reported disease; 2 = gene present in OMIM with different disease association or without disease; 3 = gene not present in OMIM. 
Flow chart of method used to classify "pathologs" Figure 2
Flow chart of method used to classify "pathologs". To iden-
tify pathologs that correspond to already known mouse 
orthologs or potential new orthologs, cDNA sequences 
were compared to known human sequences and conserva-
tion of synteny assessed using mouse to human mapping 
information. If the patholog corresponded to best mouse to 
human hit the reported function of the gene product was 
checked. Mouse sequences with reported human ortholog 
and known function were classified as "known ortholog", 
sequences reported as best mouse to human hit with 
unknown function were classified as "ortholog-candidate" 
and sequences with unknown function that did not corre-
spond to the best mouse to human hit were classified as 
"novel sequences".BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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Table 4: Pathologs related to other disorders. Representative disease is shown for each clone. *RTPS6.3 (representative transcript 
protein set 6.3) cluster representative transcriptional unit (TU) of the FANTOM2 clone set. OMIM status: 1 = gene present in OMIM 
with a reported disease; 2 = gene present in OMIM with different disease association or without disease; 3 = gene not present in OMIM.
Disease FANTOM ID DDBJ accession Gene name Disease relationship OMIM status
IMMUNOLOGICAL
Diagnosis
1500019E10* AK005285 Replication protein a 14 kda subunit Systemic lupus erythematosus 1
1810019E15 AK007546 Dek protein LES and Juvenile RA 2
2700059D02* AK012454 Uveal autoantigen Behecet's Disease, sarcoidosis and 
Vogt-Koyanagi-Harada disease
3
4632415P04* AK028516 Golgi complex autoantigen golgin-97 Sjogren's syndrome 1
D030032G01* AK050903 Neuroblast differentiation associated 
protein ahnak
Systemic lupus erythematosus 2
Pathophysiology
A630006E02* AK041380 Minor histocompatibility antigen ha-1 Graft-versus-host disease 1
B230303A05* AK045681 U1 small nuclear ribonucleoprotein c Autoimmunity to U1 snrnps 1
B230397K24* AK046480 L1 retroposon, orf2 mrna Rheumatoid arthritis 3
C330006A15* AK049133 Ribonuclease p protein subunit p38 Scleroderma autoimmune antigens 1
F830032C23* AK089843 Caspase recruitment domain protein 
15
Crohn's disease 1
NEUROLOGICAL
Pathophysiology
2210420D18 Serine/threonine kinase rick Alzheimer's disease 2
4833420A15 AK014731 Huntingtin-interacting protein-1 
protein interactor
Huntington's disease 1
9330170I02* AK034263 Metabotropic glutamate receptor 2 
precursor
Alzheimer's disease 2
B230307E07 AK045716 Excitatory amino acid transporter 1 Alzheimer's disease 3
CARDIOVASCULAR
Pathophysiology
1700127D06* AK007298 Tisuee kallilrein Hypertension 1
2510048K03* AK011112 Prolylcarboxypeptidase Essential hypertension 1
4833405G23 AK029362 Rtp801-like protein Ischemic diseases 3
9630044I02 AK036182 Mitochondrial isoleucine trna 
synthetase
Cardiomyopathy 3
B430208E24* AK046620 Ras gtpase-activating Protein 1 Neuropathology of ischemia 2
D130064D17* AK051677 Lysosomal pro-x carboxypeptidase 
precursor
Essential hypertension 3
E030024D09* AK087056 Angiotensin converting enzyme Hypertension 1
2310063B19* AK010021 Epoxide hydrolase Hhypertension 2
REPRODUCTIVE
Pathophysiology
0610007H07* Z-protein Fetal loss 3
1700010P14* AK005852 Nyd-sp6 Spermatogenesis 3
4631410O16* AK028461 Sumo-1-specific protease 1 Reproduction 1
4930406H24* AK029590 Adam 26 precursor Spermatogenesis 3
B130010I06* AK044891 Dmrt2/terra-like protein Sex differentiation disorders 3
D030049L20 AK050982 Sperm antigen Immunologic infertility 1
OTHERS
Pathophysiology
1110004H01* AK003421 Mitochondrial import inner 
membrane translocase subunit tim9 
b
Fracture healing 3
1810015E19 AK007508 Slp-1 Autism 1
1810015M19* AK019013 Lw glycoprotein Sickle cell disease 1
4932434G09* AK016547 Ribonucleases p/mrp protein subunit 
pop1
Connective tissue diseases 3
5730465G20 AK077598 N-acetyllactosaminide beta-1,6-n-
acetylglucosaminyl Transferase
Blood group I gene 3
9830131G07* AK036537 Bomapin Hematopoiesis 2
9930031F20 AK036967 Vp165 Type 2 diabetes 3BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
Page 10 of 14
(page number not for citation purposes)
no disease relationship was listed in OMIM or the disease
association listed was not the same as the one found by
our manual expert curation. Furthermore, through our
search strategy of PubMed abstracts we identified 93 addi-
tional potential pathologs not identified through OMIM.
Discussion
The mouse is the most important animal model of human
disease, hence the importance of the FANTOM project to
characterise the mouse transcriptome, complete with
functional annotation and human genome mapping. The
FANTOM2 cDNA dataset represents the most complete
set of mouse transcripts to date, and it was utilised by us
to identify potential novel pathologs. The identification of
pathologs was assisted by integrating the FANTOM2
mouse data with all scientific literature referenced by
PubMed, which is currently the most comprehensive
literature source of molecular and clinical data. The prob-
lem is that most relevant data in medical literature data-
bases is embedded in the free text and searching by
automated methods often results in the loss of informa-
tion. Therefore, to more thoroughly screen for potential
pathologs, we employed two approaches in parallel; one
relying on semi-automated sequence analysis and text
searching (FACTS) and the other relying on human expert
manual searching. The results of this study clearly indicate
the importance of using multiple parallel approaches to
identify all potential pathologs.
The semi-automated approach detected 133 (73%) of the
potential pathologs compared to 146 (80%) using
manual search. Interestingly the overlap between the two
methods was only 97 (53%), suggesting that both
approaches are required for identification of all potential
pathologs. Although the semi-automated approach uti-
lises less than one third of the time required by manual
searching, three quarters of the hits detected by this sys-
tem were classified as false positives, only 134 transcripts
out of the initial 708 produced by automated search meet-
ing the criteria for potential pathologs. This is not unusual
when using computerized systems. Problems were caused
by retrieval of irrelevant abstracts, misconstructed queries,
queries containing ambiguous gene symbols or syno-
nyms, wrong disease MeSH term associations in the
abstracts or because the abstract did not meet the human
expert's criteria for a potential patholog.
Several reasons contribute to a better performance using
the FACTS system compared to expert annotation. The
coverage and specificity of abstract retrieval from
MEDLINE depends on how queries are constructed. Man-
ual searches were performed using gene names and sym-
bols from the FANTOM2 database, while FACTS
constructed queries from an automated QueryMaker
program that extracts gene/protein names, symbols and
synonym accessions of their annotation sources (e.g.,
MGI, SwissProt). This information is integrated according
to query rules and then used to perform MEDLINE
searches. The FACTS system also combines a MeSH Term-
Matcher program with a Sentence Splitter system to iden-
tify disease associations from MEDLINE abstracts and
OMIM morbidmap database (for detailed explanation of
the FACTS system see [20]). These programs enhance the
accuracy of automated queries and searches used for the
identification of pathologs. The high frequency of false
positive hits makes manual curation an important step
when using computational screening. Whilst manual
searching produces more true positive hits, it is less effi-
cient than the semi-automated approach. Expert analysis
identified 49 clones that were missed by the automated
system as FACTS-derived results are based on MEDLINE
whilst the expert annotators used PubMed for abstract
searches.
In previous reports, pathologs in non-human organisms
were identified using the OMIM database, the problem
A130042M24* AK037730 Mucin COPD 1
A730076H11 AK043253 T-cell receptor alpha chain precursor 
v-j region
Leishmania major 3
A830007N20 AK043557 Wd-repeat protein 3 Triple-A syndrome 1
B830002B15* AK046772 Polycystic kidney disease 2-like 
protein
Cystic diseases 1
C230099M23* AK082743 Vesicular glutamate transporter 2 Schizophrenia 3
E130216C05 AK087459 Amyloid beta precursor-like protein 2 Healing corneal epithelium 2
Treatment
5033405N08* AK017155 Agmatinase Chronic pain, addictive states and 
brain injury
3
A930028N13 AK044634 Ankyrin-2 Human hemolytic anemias 2
Table 4: Pathologs related to other disorders. Representative disease is shown for each clone. *RTPS6.3 (representative transcript 
protein set 6.3) cluster representative transcriptional unit (TU) of the FANTOM2 clone set. OMIM status: 1 = gene present in OMIM 
with a reported disease; 2 = gene present in OMIM with different disease association or without disease; 3 = gene not present in OMIM. BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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with this approach being that it requires the human dis-
ease gene to be already known. Our approach produced
93 potential pathologs that were identified through the
scientific literature but were not in the OMIM database,
suggesting that the true number of pathologs is far higher
than those with strictly Mendelian inheritance. Further-
more, given that this study only focused on the subset of
"similar to" cDNA clones and did not cover those anno-
tated as "weakly similar to" (see methods) we anticipate
that there are many more pathologs in the mouse that are
yet to be identified. Our analysis also suggests that the
field of disease-related molecular databases is unders-
erved, other than the Mendelian disorders covered by
OMIM.
The pathologs identified in this study were selected from
a group of FANTOM2 mouse cDNA clones similar to, but
not identical to, other known genes. As expected,
sequence comparison revealed that the majority of
pathologs (137 or 75%) corresponded to the best mouse
to human match although many of them (65) remain to
be confirmed as orthologs as no function for them has yet
been described. We also located an extra 45 potential
pathologs that may represent mouse homologs to novel
human disease-related genes as deduced from sequence
analysis and conservation of synteny. It is likely that at
least some of the potential pathologs with function
unknown (110) will represent non-functional transcripts,
or gene products with different function. Those pathologs
that are experimentally validated as orthologs can be used
as targets for genetic manipulation and development of
mouse models of human disease.
Conclusions
This paper demonstrates the power of combining human
expert annotation with FACTS, a newly developed bioin-
formatics tool, to identify novel pathologs from within
large-scale mouse transcript datasets. Those pathologs can
be used as targets for genetic manipulation and develop-
ment of mouse models of human disease. The similarity
between mouse and human genomes and their closely-
related biochemical, physiological, and pathological
pathways makes the mouse an invaluable model organ-
ism for the study of human disease.
Methods
FANTOM2 system
The FANTOM2 set of full-length mouse cDNA clones con-
tains 60770 sequences. The FANTOM2 clones were
functionally annotated using automated computational
annotation followed by expert human curation [14].
Accession numbers
Accession numbers in the manuscript refer to FANTOM
accessions submitted to the DNA data bank of Japan
(DDBJ), or public accessions.
Sequence analysis
Pre-computed results of sequence similarity comparisons
were retrieved from the FANTOM2 database [21]. The
method used for detection of sequence similarity has been
explained by Okasaki et. al. [14]. Briefly, according to the
percentage of DNA sequence identity and the length of the
similarity region to known genes the FANTOM2 clones
were annotated as: "identical-to" or "homolog", "similar-
to", or "weakly-similar-to". "Identical to" (>95%) and
"homolog" (85–95%) were clones with more than 85%
identity over more than 90% of their length to known
genes. "Similar to" were clones with identity of 70–85%
over more than 70% of their length to known genes.
"Weakly similar to" were clones with identity between
50–70% over more than 70% of their length to known
genes.
The clones grouped as "similar to" and "weakly similar to"
could represent novel mouse transcripts whose function
may be inferred because of their similarity to known pro-
teins. This study focused on the analysis of "similar to"
clones, which are referred here to as the "target set". The
clones classified as "weakly similar to" require further bio-
informatic characterisation and therefore will be matter of
a different study. The target set was comprised of 2578
annotated clones, representing a workable size subset for
this study. Using the RIKEN clone ID number of each
potential human disease related target, we identified the
Table 5: Comparison of the OMIM entries (July 2003) with pathologs. "OMIM NDA" stands for pathology entries that are in OMIM, but 
disease association was not specified, or it was not consistent with the disease specified in PubMed abstracts. "OMIM DA" stands for 
pathologs that match both OMIM entries and disease association.
Disease OMIM NDA Not in OMIM OMIM DA Total
Cancer 26 33 37 96
Hereditary disorders 4 4 35 43
Other 9 17 17 43
T o t a l 3 95 48 9 1 8 2BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/28
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representative transcript from RTPS 6.3 [22] to indicate
the FANTOM2 cluster representative transcriptional unit
associated with disease (see Tables 2, 3, 4).
Human disease-related genes
We defined "patholog" as a non-human gene with homol-
ogy to a human gene that encodes a product (transcript,
anti-sense or proteins) involved in human disease. In this
study, to be classified as a disease-related gene, there must
be at least one scientific publication providing evidence
linking a gene (or the related protein) to a disease pheno-
type (such as protein mutation or up/down regulation),
to a diagnostic test, or to a disease treatment. In vitro stud-
ies using human cells (fresh tissue, cell lines or tumour
cell cultures) or clinical studies were all accepted as evi-
dence for a human disease relationship. Scientific publica-
tions where experiments were done using non-human
organisms or where results were not tested directly in
humans were discarded from the analysis.
All potential pathologs from the target set were used for
identification of the corresponding human gene by map-
ping to the human genome sequence. We used a semi-
automated and a manual approach for data searching and
identification of pathologs. The manual approach
involved searching literature abstracts from the PubMed
database [23] using protein names for each clone in the
target set, to identify potential human disease relation-
ships. The gene or protein name was searched via the
PubMed interface for keyword search and the retrieved
abstracts were analysed by medical experts. Queries that
returned one or more abstracts and that met the patholog
definition criteria were noted: clone ID, clone name,
PubMed ID, and disease-relationship were recorded. In
the semi-automated approach we used the FACTS (Func-
tional Association/Annotation of cDNA clones from Text/
Sequence Sources) system to query MEDLINE abstracts
(described in detail by Nagashima et al. [20]. Briefly, we
constructed MEDLINE queries from RIKEN cDNA clone
annotations using 205 query construction rules and the
FACTS MeSH TermMatcher program. Of 2578 similar to
annotated clones 1,949 clones had gene names consid-
ered informative for MEDLINE abstract searches that were
clustered into 639 queries. 522 queries corresponding to
708 clones yielded 17,051 abstracts with 2637 disease
MeSH terms. As FACTS extracts both abstract and
sequence-derived based information using accession
mapping, from the 708 clones we obtained 109 that had
92 disease associations in OMIM Morbimap. From 629
clones without informative names we extracted 47 OMIM
Morbidmap associations for 57 clones. In total FACTS
provided 27% of all and 36% of informative disease can-
didate associations. The MEDLINE and OMIM inferred
disease associations can be annotated upon registration
through a FACTS annotation interface. The interface dis-
plays basic clone information (symbol names, protein
motifs and RTPS cluster information) and links to tissue
expression information in READ [24] and GNF gene
expression atlas [25] together with the automatically
constructed query. The computationally inferred human
disease MeSH terms and OMIM Morbidmap titles are
listed in a table containing a hyperlinked MEDLINE iden-
tifier, MeSH term and check boxes to delete or confirm the
MeSH term and assign a confidence value. The confidence
values low, medium, high, and unknown indicate
whether the MeSH assignment is based on direct (e.g.
mutation in gene) or indirect (pathway component in dis-
ease gene pathway) evidence. A comment field provided
the possibility of entering evidence and decision-support-
ing comments. Automated results were obtained in 48
hours and manual curation required approximately 60
man hours.
Medical experts performed manual searches of the 2578
target clones through abstract inspection and thereby
selected candidate novel mouse pathologs. The time taken
to identify the final number of pathologs required approx-
imately 160 man hours.
Classification and interpretation
The results of the manual and the semi-automated
approaches were combined in a single final list. Clones on
this list were classified into groups in accordance to the
physiological system affected by the related disease.
Pathologs were subdivided according to the role of the
protein in the disease process: pathophysiology, diagno-
sis, or treatment. Finally, we compared the pathologs
identified in this study with entries from the OMIM data-
base to identify pathologs that could be identified by
direct searching of the OMIM database.
Identification of mouse known orthologs, ortholog-can-
didates and novel sequences was based on sequence sim-
ilarity (FANTOM2 website [21]) and conservation of
synteny based on mouse to human mapping information
(NCBI Map viewer [26]) and RIKEN-genomapper [27]
(July 2003), and reported function (Locus Link [28]
search – july 2003). Mouse sequences with reported
human ortholog and known function were classified as
"known orthologs", sequences reported as best mouse to
human match with unknown function were classified as
"ortholog-candidates" and sequences with function
unknown that did not correspond to the best mouse to
human match were grouped as "novel sequences".
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